comprehensive -WSS

comprehensive

author：explore 2025-08-19 20:47:52 - browse：1

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： AstraZeneca chief proposes a novel edit to the drug pricing bill

WSS

The biotech scorecard for Q3: 15 stock

UpToDate has a racism problem: Dr. Stanley Goldfarb

What American doctors can learn from their Israeli counterparts

Beware reading your test results before your doctor does

UpToDate has a racism problem: Dr. Stanley Goldfarb

Use doctors trained outside the U.S. to ease the physician shortage

hotspot

comprehensive

entertainment

In age of alternative facts, a scholarly course on calling out crap

House transparency, PBM reform bill gains bipartisan support

Alkermes shareholders re

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Guidelines to prevent youth baseball injuries need more muscle

Drug cartel violence flares in western Mexico after vigilante leader's killing

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Amazon on where the company's health care bets are headed next

Anesthesiologist group: stop taking Ozempic before surgery

Crinetics acromegaly drug succeeds in late

focus

Listen: Biogen's potential pivot, & Illumina's next chapter

Prescription digital therapeutics are key to pharma’s future

Why Novartis is changing the name of its research labs

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Being 'nonadherent' patient made me a more empathetic doctor

Ethical issues complicate the benefits of medical crowdfunding

hotspot

focus

leisure time

Wikipedia